Local Coverage Determination Revision — Drugs and Biologicals: Immune Globulin Intravenous (IVIg)
Effective April 1, 2008, The Centers for Medicare & Medicaid Services (CMS) announced the addition of HCPCS Code Q4097 {Injection, Immune Globulin (Privigen), intravenous, non-lyophilized (e.g., liquid) 500 mg} to Drugs and Biologicals. In response to this change, the Local Coverage Determination (LCD) for Drugs and Biologicals: Immune Globulin Intravenous (IVIg) has been revised.
Providers are also reminded that Cahaba is working toward consolidation of Part A fiscal intermediary (FI) and Part B (Carrier) policies that are currently in common. As a result of this effort, the Local Coverage Determination (LCD) for Drugs and Biologicals: Immune Globulin Intravenous {IVIg (L13075)} has been revised. The following ICD-9 codes have been added: 695.1, 710.4, V42.82
Notification of the LCD consolidation was published in an article, which was made available on the What’s New from Cahaba page of Cahaba’s Web site on April 29, 2008.
Providers are encouraged to review these revisions to ensure compliance effective April 1, 2008.
This revised LCD can be viewed on our Web site on May 15, 2008.
Page last updated: April 4, 2008
